Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management” addresses the evolving landscape of lung cancer care, covering screening, diagnosis, and treatment. This field has experienced significant transformations due to technological advancements and research breakthroughs, resulting in improved patient survival rates. This practical and clinically oriented resource provides comprehensive and evidence-based coverage authored by experts in the field. It emphasizes the growing significance of precision medicine in the planning and management of lung cancer.
Key Highlights of “Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management”:
Comprehensive Coverage: The book discusses key topics, including small cell and non-small cell lung cancers, immunotherapy, molecular cohorts (such as ROS1, BRAF, HER2, Met, and NTRK), and oligometastatic disease.
Individualized Treatment: It provides insights into tailoring treatment plans, encompassing chemotherapy, radiotherapy, targeted biomarker-derived therapies, and emerging immunotherapies.
Visual Guidance: The book includes visual aids such as algorithms, pathology specimens, anatomic drawings, PET/CT, and CT imaging to facilitate diagnosis and treatment planning.
Clinical Pearls: Each chapter starts with “Top 5 Clinical Pearls,” offering concise highlights of key insights.
Multidisciplinary Perspective: The book draws on the expertise of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists, providing a comprehensive view from a real-world tumor board perspective.
“Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management” serves as an invaluable resource for healthcare professionals involved in the care of lung cancer patients. It equips clinicians with the knowledge and insights needed to provide the best possible care in this rapidly evolving field
